Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies Read more
Exclusive Interview with Conference Speaker Martin Slegl Released Ahead of Parallel Trade 2020 Read more
Charles River and Takeda Announce Scientific Collaboration to Identify and Develop Preclinical Candidates Read more